Emergent BioSolutions (EBS) Capital Expenditures (QoQ) (2010 - 2026)
Emergent BioSolutions (EBS) Capital Expenditures (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn |
| 10 | Emergent BioSolutions | 432.85 Mn | 271.35 Mn | 84.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 128.92% |
| Dec 31, 2025 | -207.79% |
| Sep 30, 2025 | 1,000.00% |
| Jun 30, 2025 | -53.33% |
| Mar 31, 2025 | 400.00% |
| Dec 31, 2024 | 102.17% |
| Sep 30, 2024 | -400.00% |
| Jun 30, 2024 | -57.41% |
| Mar 31, 2024 | -74.53% |
| Dec 31, 2023 | 2,726.67% |
| Sep 30, 2023 | 1,600.00% |
| Jun 30, 2023 | -101.28% |
| Mar 31, 2023 | 109.42% |
| Dec 31, 2022 | -396.77% |
| Sep 30, 2022 | -45.29% |
| Jun 30, 2022 | 283.46% |
| Mar 31, 2022 | -70.96% |
| Dec 31, 2021 | -17.03% |
| Sep 30, 2021 | -39.07% |
| Jun 30, 2021 | 178.77% |